Trichet V - Search Results

1

Modifying internal organization and surface morphology of siRNA lipoplexes by sodium alginate addition for efficient siRNA delivery.

Arruda DC, Gonzalez IJ, Finet S, Cordova L, Trichet V, Andrade GF, Hoffmann C, Bigey P, de Almeida Macedo WA, Da Silva Cunha A Jr, Malachias de Souza A, Escriou V. Arruda DC, et al. Among authors: trichet v. J Colloid Interface Sci. 2019 Mar 22;540:342-353. doi: 10.1016/j.jcis.2019.01.043. Epub 2019 Jan 14. J Colloid Interface Sci. 2019. PMID: 30660791

2

Lipid nanoparticles for siRNA delivery in lungs.

Trichet V, Layrolle P, Escriou V. Trichet V, et al. Nanomedicine (Lond). 2012 Feb;7(2):181-3. doi: 10.2217/nnm.12.4. Nanomedicine (Lond). 2012. PMID: 22339131 No abstract available.

3

Inhibition of osteolysis and increase of bone formation after local administration of siRNA-targeting RANK in a polyethylene particle-induced osteolysis model.

Córdova LA, Trichet V, Escriou V, Rosset P, Amiaud J, Battaglia S, Charrier C, Berreur M, Brion R, Gouin F, Layrolle P, Passuti N, Heymann D. Córdova LA, et al. Among authors: trichet v. Acta Biomater. 2015 Feb;13:150-8. doi: 10.1016/j.actbio.2014.10.042. Epub 2014 Nov 20. Acta Biomater. 2015. PMID: 25462844

4

Oncogene silencing by systemic delivery of lipid nanoparticle.

Trichet V, Layrolle P, Escriou V. Trichet V, et al. Nanomedicine (Lond). 2012 Feb;7(2):182. Nanomedicine (Lond). 2012. PMID: 22451970 No abstract available.

5

Sheddable PEG for deshielding siRNA nanoparticles in the tumor acid microenvironment.

Trichet V, Layrolle P, Escriou V. Trichet V, et al. Nanomedicine (Lond). 2012 Feb;7(2):182-3. Nanomedicine (Lond). 2012. PMID: 22451971 No abstract available.

6

Advantages of bioluminescence imaging to follow siRNA or chemotherapeutic treatments in osteosarcoma preclinical models.

Rousseau J, Escriou V, Perrot P, Picarda G, Charrier C, Scherman D, Heymann D, Rédini F, Trichet V. Rousseau J, et al. Among authors: trichet v. Cancer Gene Ther. 2010 Jun;17(6):387-97. doi: 10.1038/cgt.2009.89. Epub 2010 Jan 15. Cancer Gene Ther. 2010. PMID: 20075983

7

Formulated siRNAs targeting Rankl prevent osteolysis and enhance chemotherapeutic response in osteosarcoma models.

Rousseau J, Escriou V, Lamoureux F, Brion R, Chesneau J, Battaglia S, Amiaud J, Scherman D, Heymann D, Rédini F, Trichet V. Rousseau J, et al. Among authors: trichet v. J Bone Miner Res. 2011 Oct;26(10):2452-62. doi: 10.1002/jbmr.455. J Bone Miner Res. 2011. PMID: 21713988 Free article.

8

Osteoblasts mineralization and collagen matrix are conserved upon specific Col1a2 silencing.

Maruelli S, Besio R, Rousseau J, Garibaldi N, Amiaud J, Brulin B, Layrolle P, Escriou V, Rossi A, Trichet V, Forlino A. Maruelli S, et al. Among authors: trichet v. Matrix Biol Plus. 2020 Jan 31;6-7:100028. doi: 10.1016/j.mbplus.2020.100028. eCollection 2020 May. Matrix Biol Plus. 2020. PMID: 33543025 Free PMC article.

9

Orthopaedic implant failure: aseptic implant loosening--the contribution and future challenges of mouse models in translational research.

Cordova LA, Stresing V, Gobin B, Rosset P, Passuti N, Gouin F, Trichet V, Layrolle P, Heymann D. Cordova LA, et al. Among authors: trichet v. Clin Sci (Lond). 2014 Sep;127(5):277-93. doi: 10.1042/CS20130338. Clin Sci (Lond). 2014. PMID: 24827940 Free article. Review.

10

Allele-specific Col1a1 silencing reduces mutant collagen in fibroblasts from Brtl mouse, a model for classical osteogenesis imperfecta.

Rousseau J, Gioia R, Layrolle P, Lieubeau B, Heymann D, Rossi A, Marini JC, Trichet V, Forlino A. Rousseau J, et al. Among authors: trichet v. Eur J Hum Genet. 2014 May;22(5):667-74. doi: 10.1038/ejhg.2013.198. Epub 2013 Sep 11. Eur J Hum Genet. 2014. PMID: 24022296 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68 results

Search Page